Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Canani, Luís Henrique ^a   Copstein, Eduardo ^a   Pecis, Miriam ^a   Friedman, Rogério ^a   Leitão, Cristiane Bauermann ^a   Azevedo, Mirela Jobim ^a   Triches, Cristina ^a   Rados, Dimitris Rucks Varvaki ^a   Moreas, Ruy Silveira ^a   Gross, Jorge Luiz ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Autonomic neuropathy; Diabetes; Diabetic neuropathy

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOLOGY; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FUNCTION TEST; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

EID: 84884515155     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-54     Document Type: Article

References (26)

1. Diabetes as an atherogenic factor. Ruderman NBH C, Prog Cardiovasc Dis 1984 26 373 412 10.1016/0033-0620(84)90011-2 6371895 (Pubitemid 14170169)
2. Update on some epidemiologic features of intermittent claudication: the Framingham study. Kannel WBM DL, J Am Geriatr Soc 1985 33 8 13
3. Lower-extremity arterial calcification as a correlate of coronary artery calcification. Costacou T, Huskey ND, Edmundowicz D, Stolk R, Orchard TJ, Metabolism 2006 55 1689 1696 10.1016/j.metabol.2006.08.012 17142145 (Pubitemid 44827138)
4. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR, Circulation 1999 100 1134 1146 10.1161/01.CIR.100.10.1134 10477542 (Pubitemid 29416243)
5. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA, Diabet Med 1993 10 820 824 10.1111/j.1464-5491.1993.tb00173.x 8281726 (Pubitemid 23326833)
6. Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Gottsater A, Ahlgren AR, Taimour S, Sundkvist G, Clin Auton Res 2006 16 228 234 10.1007/s10286-006-0345-4 16763752 (Pubitemid 43885550)
7. Cardiovascular autonomic neuropathy associated with carotid atherosclerosis in type 2 diabetic patients. Gottsater A, Ryden-Ahlgren A, Szelag B, Hedblad B, Persson J, Berglund G, Wroblewski M, Sundkvist G, Diabet Med 2003 20 495 499 10.1046/j.1464-5491.2003.00956.x 12786687 (Pubitemid 36776013)
8. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Ewing DJ, Martyn CN, Young RJ, Clarke BF, Diabetes Care 1985 8 491 498 10.2337/diacare.8.5.491 4053936 (Pubitemid 15240914)
9. Heart rate variability measurement in diabetic neuropathy: review of methods. Risk M, Bril V, Broadbridge C, Cohen A, Diabetes Technol Ther 2001 3 63 76 10.1089/152091501750220028 11469709 (Pubitemid 32405677)
10. Three-dimensional return map: a new tool for quantification of heart rate variability. Moraes RS, Ferlin EL, Polanczyk CA, Rohde LE, Zaslavski L, Gross JL, Ribeiro JP, Auton Neurosci 2000 83 90 99 10.1016/S0165-1838(00)00095-3 11023634
11. Value of diagnostic tools for myocardial ischemia used in routine clinical practice to predict cardiac events in patients with type 2 diabetes mellitus: a prospective study. Azevedo MJ, Neto AF, Caramori ML, Beck MO, Moreira JS, Ludwig R, Gross JL, Arq Bras Endocrinol Metabol 2006 50 46 52 10.1590/S0004-27302006000100007 16628274 (Pubitemid 43748320)
12. Cardiovascular survey methods. Rose GA, Blackburn H, Monogr Ser World Health Organ 1968 56 1 188 4972212
13. Diabetic nephropathy: diagnosis, prevention, and treatment. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T, Diabetes Care 2005 28 164 176 10.2337/diacare.28.1.164 15616252 (Pubitemid 40095801)
14. Standards of medical care in diabetes - 2012. American Diabetes Association, Diabetes Care 2012 35 Suppl 1 11 S63 22187469
15. Standards of medical care in diabetes-2013. American Diabetes Association, Diabetes Care 2013 36 11 S66 23264422
16. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA, Diabetes Care 1994 17 1281 1289 10.2337/diacare.17.11.1281 7821168 (Pubitemid 24324972)
17. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans, Louisiana. Orchard TJ, Strandness DE Jr, Circulation 1993 88 819 828 10.1161/01.CIR.88.2.819 8339448
18. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. Kahn R, Diabetes Care 1992 15 1095 1103 1505319
19. Effect of age and sex on glomerular filtration rate measured by 51Cr-EDTA. Gross JL, Friedman R, Azevedo MJ, Silveiro SP, Pecis M, Braz J Med Biol Res 1992 25 129 134 1339508
20. Sympathetic nervous system representation in time and frequency domain indices of heart rate variability. Polanczyk C, Rohde L, Moraes R, Ferlin E, Leite C, Ribeiro J, Eur J Appl Physiol 1999 79 69 73
21. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh artery study. MacGregor AS, Price JF, Hau CM, Lee AJ, Carson MN, Fowkes FG, Diabetes Care 1999 22 453 458 10.2337/diacare.22.3.453 10097928 (Pubitemid 29106904)
22. Power spectral analysis of heart rate variation in diabetic patients with neuropathic foot ulceration. Aso Y, Fujiwara Y, Inukai T, Takemura Y, Diabetes Care 1998 21 1173 1177 10.2337/diacare.21.7.1173 9653615 (Pubitemid 28368528)
23. 5-Year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K, Circulation 1990 82 27 36 10.1161/01.CIR.82.1.27 2194696 (Pubitemid 20216312)
24. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G, Diabetes 2002 51 3524 3531 10.2337/diabetes.51.12.3524 12453910 (Pubitemid 35403460)
25. Vascular risk factors and diabetic neuropathy. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH, Group EPCS, N Engl J Med 2005 352 341 350 10.1056/NEJMoa032782 15673800
26. Does the cardiac autonomic response to postural change predict incident coronary heart disease and mortality? The Atherosclerosis Risk in Communities Study. Carnethon MR, Liao D, Evans GW, Cascio WE, Chambless LE, Rosamond WD, Heiss G, Am J Epidemiol 2002 155 48 56 10.1093/aje/155.1.48 11772784 (Pubitemid 34042432)